Green tea catechins inhibit angiogenesis through suppression of STAT3 activation

Breast Cancer Research and Treatment

Volumn 117, Issue 3, 2009, Pages 505-515

  Leong, Hoyee ^a,b   Mathur, Priya S ^a   Greene, Geoffrey L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University HealthSystem Consortium   (United States)

Author keywords

Angiogenesis; Breast cancer; Green tea; STAT3

Indexed keywords

ANGIOGENESIS INHIBITOR; CATECHIN; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; GELATINASE B; GREEN TEA EXTRACT; POLYPHENON E; STAT1 PROTEIN; STAT3 PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BREAST CANCER; CELL MIGRATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEA;

BREAST NEOPLASMS; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTERFERON-GAMMA; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; TEA; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349568369     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0196-x     Document Type: Article

References (45)

1. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31 10.1038/nm0195-27 7584949 10.1038/nm0195-27 1:CAS:528:DyaK2MXjs1KnsLk%3D
2. M Atiqur Rahman M Toi 2003 Anti-angiogenic therapy in breast cancer Biomed Pharmacother 57 463 470 10.1016/j.biopha.2003.09.009 14637390 10.1016/j.biopha.2003.09.009 1:CAS:528:DC%2BD3sXpt1Whs7Y%3D (Pubitemid 37452416)
3. LS Rosen 2005 VEGF-targeted therapy: therapeutic potential and recent advances Oncologist 10 382 391 10.1634/theoncologist.10-6-382 15967832 10.1634/theoncologist.10-6-382 1:CAS:528:DC%2BD2MXovVOrs78%3D (Pubitemid 40993566)
4. AJ Guidi SJ Schnitt L Fischer K Tognazzi JR Harris HF Dvorak LF Brown 1997 Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast Cancer 80 1945 1953 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID- CNCR11>3.0.CO;2-Y 9366297 10.1002/(SICI)1097-0142(19971115)80:10<1945:: AID-CNCR11>3.0.CO;2-Y 1:STN:280:DyaK1c%2FjtFKhtw%3D%3D (Pubitemid 27479789)
5. JA Foekens HA Peters N Grebenchtchikov MP Look ME Meijer-van Gelder A Geurts-Moespot TH van der Kwast CG Sweep JG Klijn 2001 High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer Cancer Res 61 5407 5414 11454684 1:CAS:528: DC%2BD3MXnsVCru7o%3D
6. AL Thomas B Morgan J Drevs C Unger B Wiedenmann U Vanhoefer D Laurent M Dugan WP Steward 2003 Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584 Semin Oncol 30 32 38 12802793 1:CAS:528:DC%2BD3sXlsFelt7w%3D
7. RP Singh G Sharma S Dhanalakshmi C Agarwal R Agarwal 2003 Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis Cancer Epidemiol Biomarkers Prev 12 933 939 14504208 1:CAS:528:DC%2BD3sXnsValt7c%3D
8. JL Arbiser N Klauber R Rohan R van Leeuwen MT Huang C Fisher E Flynn HR Byers 1998 Curcumin is an in vivo inhibitor of angiogenesis Mol Med 4 376 383 10780880 1:CAS:528:DyaK1cXksFKktbc%3D
9. EC Kim JK Min TY Kim SJ Lee HO Yang S Han YM Kim YG Kwon 2005 [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo Biochem Biophys Res Commun 335 300 308 10.1016/j.bbrc.2005.07.076 16081047 10.1016/j.bbrc.2005.07.076 1:CAS:528:DC%2BD2MXnslOqsLo%3D (Pubitemid 41140221)
10. JS Park MH Kim HJ Chang KM Kim SM Kim BA Shin BW Ahn YD Jung 2006 Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2 Int J Oncol 29 1247 1252 17016658 1:CAS:528:DC%2BD28Xht1Wjs7jI
11. LS Rosen 2002 Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers Cancer Control 9 36 44 11965229
12. G Fassina R Vene M Morini S Minghelli R Benelli DM Noonan A Albini 2004 Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate Clin Cancer Res 10 4865 4873 10.1158/1078-0432.CCR- 03-0672 15269163 10.1158/1078-0432.CCR-03-0672 1:CAS:528:DC%2BD2cXlvVegsL8%3D (Pubitemid 38955541)
13. CS Yang P Maliakal X Meng 2002 Inhibition of carcinogenesis by tea Annu Rev Pharmacol Toxicol 42 25 54 10.1146/annurev.pharmtox.42.082101.154309 11807163 10.1146/annurev.pharmtox.42.082101.154309 1:CAS:528: DC%2BD38XhvFKnsLg%3D (Pubitemid 34160518)
14. M Masuda M Suzui JT Lim IB Weinstein 2003 Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells Clin Cancer Res 9 3486 3491 12960141 1:CAS:528:DC%2BD3sXotFCkt70%3D
15. H Fujiki M Suganuma M Kurusu S Okabe Y Imayoshi S Taniguchi T Yoshida 2003 New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen Mutat Res 523-524 119 125 10.1016/S0027-5107(02)00327- 5 12628509 (Pubitemid 36293238)
16. S Bettuzzi M Brausi F Rizzi G Castagnetti G Peracchia A Corti 2006 Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Res 66 1234 1240 10.1158/0008-5472.CAN-05-1145 16424063 10.1158/0008-5472.CAN-05-1145 1:CAS:528:DC%2BD28XlsFOmsA%3D%3D (Pubitemid 43165995)
17. J Clark M You 2006 Chemoprevention of lung cancer by tea Mol Nutr Food Res 50 144 151 10.1002/mnfr.200500135 16425282 10.1002/mnfr.200500135 1:CAS:528:DC%2BD28XisVaitbw%3D (Pubitemid 43325655)
18. CL Sun JM Yuan WP Koh MC Yu 2006 Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies Carcinogenesis 27 1310 1315 10.1093/carcin/bgi276 16311246 10.1093/carcin/bgi276 1:CAS:528: DC%2BD28XmsVegtr0%3D (Pubitemid 43985405)
19. FY Tang M Meydani 2001 Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production Nutr Cancer 41 119 125 10.1207/S15327914NC41-1&2-17 12094614 10.1207/S15327914NC41-1&2-17 1:CAS:528:DC%2BD38XlsVehsr0%3D
20. S Lamy D Gingras R Beliveau 2002 Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation Cancer Res 62 381 385 11809684 1:CAS:528:DC%2BD38XhtVyhsbc%3D
21. M Masuda M Suzui JT Lim A Deguchi JW Soh IB Weinstein 2002 Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction J Exp Ther Oncol 2 350 359 10.1046/j.1359-4117.2002.01062.x 12440226 10.1046/j.1359-4117.2002.01062.x 1:CAS:528:DC%2BD38XovFaksL8%3D (Pubitemid 35265984)
22. A Kojima-Yuasa JJ Hua DO Kennedy I Matsui-Yuasa 2003 Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors Life Sci 73 1299 1313 10.1016/S0024-3205(03)00424-7 12850245 10.1016/S0024-3205(03)00424-7 1:CAS:528:DC%2BD3sXltF2ntrs%3D (Pubitemid 36794594)
23. FY Tang N Nguyen M Meydani 2003 Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule Int J Cancer 106 871 878 10.1002/ijc.11325 12918064 10.1002/ijc.11325 1:CAS:528:DC%2BD3sXnsVGrsLk%3D (Pubitemid 37071665)
24. S Garbisa L Sartor S Biggin B Salvato R Benelli A Albini 2001 Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate Cancer 91 822 832 10.1002/1097-0142(20010215)91: 4<822::AID-CNCR1070>3.0.CO;2-G 11241252 10.1002/1097-0142(20010215)91: 4<822::AID-CNCR1070>3.0.CO;2-G 1:CAS:528:DC%2BD3MXhsFCrtLk%3D (Pubitemid 32173309)
25. SK Rodriguez W Guo L Liu MA Band EK Paulson M Meydani 2006 Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex Int J Cancer 118 1635 1644 10.1002/ijc.21545 16217757 10.1002/ijc.21545 1:CAS:528:DC%2BD28XislKlsrY%3D (Pubitemid 43376426)
26. JF Bromberg MH Wrzeszczynska G Devgan Y Zhao RG Pestell C Albanese JE Darnell Jr 1999 Stat3 as an oncogene Cell 98 295 303 10.1016/S0092-8674(00) 81959-5 10458605 10.1016/S0092-8674(00)81959-5 1:CAS:528:DyaK1MXlt1Cgt7s%3D (Pubitemid 29380565)
27. H Leong JR Sloan PD Nash GL Greene 2005 Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha Mol Endocrinol 19 2930 2942 10.1210/me.2005-0178 16051668 10.1210/me.2005-0178 1:CAS:528:DC%2BD2MXht12nu77M (Pubitemid 41697712)
28. H Leong P Mathur G Greene 2007 Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea Breast Cancer Res Treat 107 3 359 369 17484049 10.1007/s10549-007-9568-x
29. CV Clevenger 2004 Roles and regulation of stat family transcription factors in human breast cancer Am J Pathol 165 1449 1460 15509516 1:CAS:528:DC%2BD2cXhtVCgsLbF
30. EB Haura J Turkson R Jove 2005 Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer Nat Clin Pract Oncol 2 315 324 10.1038/ncponc0195 16264989 10.1038/ncponc0195 1:CAS:528:DC%2BD2MXlvFChtr0%3D (Pubitemid 40903176)
31. MM Brierley EN Fish 2005 Stats: multifaceted regulators of transcription J Interferon Cytokine Res 25 733 744 10.1089/jir.2005.25.733 16375601 10.1089/jir.2005.25.733 1:CAS:528:DC%2BD2MXhtlCnsrnL (Pubitemid 43071210)
32. MR Sartippour ZM Shao D Heber P Beatty L Zhang C Liu L Ellis W Liu VL Go MN Brooks 2002 Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells J Nutr 132 2307 2311 12163680 1:CAS:528:DC%2BD38XmtF2qt7o%3D
33. T Kondo T Ohta K Igura Y Hara K Kaji 2002 Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding Cancer Lett 180 139 144 10.1016/S0304-3835(02)00007-1 12175544 10.1016/S0304-3835(02)00007-1 1:CAS:528:DC%2BD38XivVSgtLw%3D (Pubitemid 34327366)
34. YD Jung MS Kim BA Shin KO Chay BW Ahn W Liu CD Bucana GE Gallick LM Ellis 2001 EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells Br J Cancer 84 844 850 10.1054/bjoc.2000.1691 11259102 10.1054/bjoc.2000.1691 1:CAS:528: DC%2BD3MXivVGrt7Y%3D (Pubitemid 32275661)
35. PC Heinrich I Behrmann S Haan HM Hermanns G Muller-Newen F Schaper 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 1 20 10.1042/BJ20030407 12773095 10.1042/BJ20030407 1:CAS:528:DC%2BD3sXmtF2hurs%3D (Pubitemid 37046923)
36. M Kubo T Hanada A Yoshimura 2003 Suppressors of cytokine signaling and immunity Nat Immunol 4 1169 1176 10.1038/ni1012 14639467 10.1038/ni1012 1:CAS:528:DC%2BD3sXpt1Snt7o%3D (Pubitemid 37540685)
37. H Yu R Jove 2004 The STATs of cancer-new molecular targets come of age Nat Rev Cancer 4 97 105 10.1038/nrc1275 14964307 10.1038/nrc1275 1:CAS:528:DC%2BD2cXhtlaqtb0%3D
38. R Buettner LB Mora R Jove 2002 Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention Clin Cancer Res 8 945 954 11948098 1:CAS:528:DC%2BD38XjsF2lsb4%3D
39. M Kortylewski R Jove H Yu 2005 Targeting STAT3 affects melanoma on multiple fronts Cancer Metastasis Rev 24 315 327 10.1007/s10555-005-1580-1 15986140 10.1007/s10555-005-1580-1 1:CAS:528:DC%2BD2MXls1agsbg%3D (Pubitemid 40922802)
40. JV Alvarez PG Febbo S Ramaswamy M Loda A Richardson DA Frank 2005 Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors Cancer Res 65 5054 5062 10.1158/0008-5472.CAN-04-4281 15958548 10.1158/0008-5472.CAN-04-4281 1:CAS:528:DC%2BD2MXltFemtb8%3D (Pubitemid 40827313)
41. TN Dechow L Pedranzini A Leitch K Leslie WL Gerald I Linkov JF Bromberg 2004 Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C Proc Natl Acad Sci USA 101 10602 10607 10.1073/pnas.0404100101 15249664 10.1073/pnas.0404100101 1:CAS:528: DC%2BD2cXmtFWmsLc%3D (Pubitemid 38955788)
42. G Niu KL Wright M Huang L Song E Haura J Turkson S Zhang T Wang D Sinibaldi D Coppola R Heller LM Ellis J Karras J Bromberg D Pardoll R Jove H Yu 2002 Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Oncogene 21 2000 2008 10.1038/sj.onc.1205260 11960372 10.1038/sj.onc.1205260 1:CAS:528:DC%2BD38XivVelur4%3D
43. FC Hsieh G Cheng J Lin 2005 Evaluation of potential Stat3-regulated genes in human breast cancer Biochem Biophys Res Commun 335 292 299 10.1016/j.bbrc.2005.07.075 16081048 10.1016/j.bbrc.2005.07.075 1:CAS:528:DC%2BD2MXnslOqsL0%3D (Pubitemid 41140220)
44. N Diaz S Minton C Cox T Bowman T Gritsko R Garcia I Eweis M Wloch S Livingston E Seijo A Cantor JH Lee CA Beam D Sullivan R Jove CA Muro-Cacho 2006 Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression Clin Cancer Res 12 20 28 10.1158/1078-0432.CCR-04-1749 16397019 10.1158/1078-0432. CCR-04-1749 1:CAS:528:DC%2BD28Xht1Glug%3D%3D (Pubitemid 43166171)
45. EC Stuart MJ Scandlyn RJ Rosengren 2006 Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer Life Sci 79 2329 2336 10.1016/j.lfs.2006.07.036 16945390 10.1016/j.lfs.2006.07.036 1:CAS:528:DC%2BD28Xht1Sgtr3K (Pubitemid 44772933)